Bayer Ag (adr) Stock News

NEW YORK , March 10, 2022 /PRNewswire/ -- The micro packaging market''s potential growth difference is likely to increase by USD 1.35 billion from 2021 to 2026, as per the latest market outlook report by Technavio. The report also identifies the market to witness a decelerating growth momentum at a CAGR of 16.81% during this forecast period. To know exact growth variance and the Y-O-Y growth rate Read our free sample report . The increasing usage in the pharmaceutical industry, growing demand for sustainable packaging, and surging demand for micro-perforated food packaging for perishable food products will offer immense growth opportunities. However, factors such as hazards of nanotechnology in food packaging, high cost of manufacturing leading to slow adoption rate. and rising environmental concerns over petroleum-derived plastic materials will challenge the growth of the market participants. View Market Report Outlook for more insights on Drivers and Challenges influencing the market growth Micro Packaging Market Segment Highlights End-user Food And Beverage The food and beverage segment held the largest micro packaging market share in 2021.

Bayer has agreed to sell its environmental science professional business to Cinven for $2.6 billion.

HOUSTON (ICIS)--German crop chemicals and pharmaceuticals major Bayer has agreed to sell its pest control business to private equity firm Cinven for $2.6bn. The business - Environmental Science…

Deal is the latest in a number of divestments by Bayer

Bayer (BAYRY) submits regulatory applications to the FDA and the EMA, seeking approval for a new indication of Nubeqa for treating metastatic hormone-sensitive prostate cancer.

The sale of the Germany pharmaceutical company’s U.S.-based unit, Environmental Science Professional, is its latest step to lower debt as it continues to defend legal claims related to Monsanto.

Bayer (BAYRY) (BAYZF) is selling its Environmental Science Professional business to Private equity firm Cinven for $2.6B which would allow it to focus on its core…

By Ludwig Burger (Reuters) – Bayer has agreed to sell a unit making pest control chemicals for landscaping and facility management to private equity group Cinven for $2.6 billion to cut debt and focus its crop science business on its core farming clientele.

Germany''s Bayer sells pest business for 2.6 billion

German chemical and health care company Bayer says it is selling a U.S.-based pest control business to private equity firm Cinven for $2.6 billion

…

By Cecilia Butini Bayer AG is selling its environmental science business to private-equity firm Cinven for $2.6 billion, the company said Thursday. The…

Here is how Bayer Aktiengesellschaft (BAYRY) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Bayer (BAYZF) submitted applications to the U.S. and EU drug regulators seeking approval of Nubeqa (darolutamide) in combination with chemotherapy docetaxel in patients with…

Vivante Health, a Houston, MA-based digital solution for digestive health and disease, raised $16m in Series A funding round. The round was led by 7wireVentures, joined by new investors Human Capital, Intermountain Ventures, SemperVirens, Elements Health Ventures, and Leaps by Bayer and returning investors FCA Venture Partners, NFP Ventures, Lifeforce Capital, and Big Pi Ventures. The company […] The post Vivante Health Raises $16M in Series A Funding appeared first on FinSMEs .